Moderna
Tracked across 13 events · 254 articles · First seen May 20, 2025 · Last active Jun 26, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: Moderna is the developer of the mFlusiva mRNA flu vaccine, which is currently under review for approval by the United States — Food and Drug Administration. The positive recommendation from the advisory panel is a significant step towards market entry, potentially boosting its stock and market position in the vaccine sector.
Jun 18, 2026 · 28 articles
Tech
Impact: Moderna is the clinical-stage biotechnology company developing the gene therapy SRD-002 for heart failure with preserved ejection fraction (HFpEF) and heart failure with reduced ejection fraction (HFrEF). The positive DMC recommendation for its MUSIC-HFpEF trial and the ongoing MUSIC-HFrEF trial are significant milestones for the company, supporting its continued advancement in cardiovascular gene therapy.
Jun 25, 2026 · 6 articles
Business
Impact: Moderna's co-founder, Robert Langer, spoke at NextRise 2026 on bio innovation, indirectly associating Moderna with the event's focus on cutting-edge technologies.
Jun 26, 2026 · 8 articles
Tech
Impact: Moderna is mentioned in the context of a potential combination therapy with Immatics' anzu-cel, indicating future collaborative possibilities in PRAME-directed treatments.
Apr 17, 2026 · 7 articles
100
Moderna announced recommendationMedera SRD-002 HFpEF Trial Advances
95
Moderna sought approval United States — Food and Drug AdministrationFDA Panel Recommends...
95
Moderna announced positive voteFDA Panel Recommends...
95
United States — Food and Drug Administration debated vaccine ModernaFDA Panel Recommends...
80
United States — Food and Drug Administration published favorable review ModernaFDA Panel Recommends...
80
United States — Food and Drug Administration will discuss ModernaMedera SRD-002 HFpEF Trial Advances
70
United States — Food and Drug Administration accepted application ModernaFDA Panel Recommends...
60
Vinay Prasad blocked application ModernaFDA Panel Recommends...
50
Moderna challenged decision United States — Food and Drug AdministrationFDA Panel Recommends...
40
Moderna reported data American Heart AssociationMedera SRD-002 HFpEF Trial Advances
Vinay Prasad
regulator
↔
Moderna
As a senior FDA official, Vinay Prasad was involved in regulatory decisions rega
+ 74 more relationships
View on Dashboard
ERGEN INTELLIGENCE
Track Moderna live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard